Episode 5

full
Published on:

13th Jan 2026

Exploring Condensate Science: A New Frontier in Treating Ovarian Cancer and ALS

In this episode of Drug Diaries, Dr. Bede Portz discusses the field of condensate biology and its potential impact on drug discovery. Condensates are membrane-less structures in cells that provide an intermediate level of organization between randomness and membrane-encompassed organelles. By studying condensates, researchers can gain new insights into cellular processes and develop innovative approaches to treating complex diseases. One of the key challenges in drug discovery is targeting difficult proteins like the MYC protein, which plays a critical role in cancer growth and proliferation. Dewpoint, where Dr. Portz works, is focusing on developing treatments for ovarian cancer by targeting the MYC protein. The use of condensate science in drug discovery offers a new lens through which complex cellular processes can be understood and manipulated. Keywords condensate biology, drug discovery, cellular processes, MYC protein, ovarian cancer, condensate science Takeaways Condensates are membrane-less structures in cells that provide an intermediate level of organization between randomness and membrane-encompassed organelles. Studying condensates can provide new insights into cellular processes and offer innovative approaches to treating complex diseases. Targeting difficult proteins like the MYC protein, which plays a critical role in cancer growth and proliferation, is a key challenge in drug discovery. Dewpoint is focusing on developing treatments for ovarian cancer by targeting the MYC protein using condensate science. Condensate science offers a new lens through which complex cellular processes can be understood and manipulated in drug discovery. Titles Exploring the Fascinating World of Condensate Biology Rewriting the Rules of Drug Discovery with Condensate Science Sound Bites "Condensate science brings a paradigm shift to drug discovery." "Condensate science offers a new lens through which we can understand and manipulate complex cellular processes." "The MYC protein is a challenging target in cancer treatment." Chapters 00:00 Introduction to Condensate Biology 06:10 Condensate Science in Drug Discovery 08:37 Condensates as Integrating Nodes of Disease 31:43 The Future of Drug Development: Insights from Condensate Biology

Listen for free

Show artwork for Drug Diaries

About the Podcast

Drug Diaries
Welcome to "Drug Diaries," the podcast exploring pharmaceuticals, life sciences, and biotechnology. Host Kaushik Trivedi, with over two decades of industry experience, shares his expertise. Kaushik has worked with IQVIA, Cognizant, Wipro, and more, and holds degrees in pharmaceutical chemistry, marketing, and advertising. Kaushik's expertise spans: - Data-Driven GTM & Customer Engagement - CRM, Marketing Cloud, SFE, & Commercial Analytics - AI/ML/NLP in Life Sciences - Population Health Management - IoT & Connected Devices - Content Production & MLR Approval - R&D, Clinical, Pharmacovigilance, Medical, & Regulatory - Business Transformation "Drug Diaries" covers research, drug discovery, AI in health, GTM strategies, customer engagement, analytics, patient safety, product engineering, and more. Join Kaushik for insights and discussions on the ever-evolving pharma and biotech landscape. Each episode is a deep dive into the industry's heart. Welcome to "Drug Diaries."

About your host

Profile picture for Kaushik Trivedi

Kaushik Trivedi